The tweet was deleted by the author.
But we saved everything 🙂.
Grant Cardone, CEO / Founder — Cardone Enterprises; Founder & CEO — Cardone Capital (real estate investment platform), reports that Bob Duggan, CEO of cancer drug developer Summit Technologies (SMMT), is investing an additional $50 million into his company. Duggan, formerly CEO of Pharmacyclics, previously sold that company to Abbvie for $21 billion in cash. Duggan reportedly holds a personal net worth of $14 billion and already owns 580 million shares of Summit Technologies.
View post on X Loading...
Cardone has addressed large asset movements in previous commentary. He recently highlighted Saylor’s sale of 32 BTC out of more than 843,000, noting the sale represented only a small fraction of total holdings. In a separate post, Cardone stated that the recent Bitcoin selloff driven by AI adoption was not tied to underlying business fundamentals.